• CD40 and STING Competition Drives B Cell Activation in ESCC

  2026-08-04

  A recent study elucidates how CD40 and STING competitively bind TRAF2 to regulate IRF4-mediated B cell activation within tertiary lymphoid structures in esophageal squamous cell carcinoma (ESCC). This mechanistic insight refines our understanding of antitumor immunity and highlights new avenues for biomarker and therapeutic strategy development.

• GCG Disrupts SARS-CoV-2 Nucleocapsid LLPS to Inhibit Replica

  2026-08-04

  Zhao et al. elucidate how the SARS-CoV-2 nucleocapsid protein undergoes RNA-induced liquid–liquid phase separation (LLPS), a process critical for viral replication and assembly. The study demonstrates that (-)-gallocatechin gallate (GCG), a green tea polyphenol, can inhibit this LLPS and thereby suppress SARS-CoV-2 replication, offering new mechanistic insights and therapeutic leads.

• BipD-Driven Mitophagy Enables Burkholderia pseudomallei Evas

  2026-08-03

  A recent study uncovers how Burkholderia pseudomallei exploits the host's mitophagy pathway via its BipD protein, promoting intracellular survival. These findings advance understanding of bacterial manipulation of mitochondrial quality control, with significant implications for infection biology and autophagy assays.

• Malate ((S)-2-hydroxysuccinic acid): Protocols for TCA Cycle

  2026-08-03

  Malate, a central metabolic intermediate, empowers researchers to dissect mitochondrial and immunometabolic dynamics in disease models. This article delivers experimental workflows, troubleshooting strategies, and unique translational insights leveraging APExBIO’s validated malate for advanced TCA cycle and metabolic reprogramming assays.

• Difloxacin HCl: Advanced Workflows for Microbial and MDR Res

  2026-08-02

  Difloxacin HCl stands out as a quinolone antimicrobial antibiotic bridging robust antimicrobial susceptibility testing and multidrug resistance reversal. Explore optimized protocols, troubleshooting strategies, and experimental enhancements for both microbiology and oncology labs, all leveraging APExBIO’s high-purity research reagent.

• Optimizing Oxidative Stress Assays with 2',7'-Dichlorofluore

  2026-08-01

  This article delivers scenario-driven, evidence-based guidance for using 2',7'-Dichlorofluorescein diacetate (SKU C3381) in sensitive intracellular ROS assays. Drawing on validated workflows and current literature, we address real-world challenges in assay design, probe selection, and data interpretation, highlighting how APExBIO's formulation supports reproducible, quantitative oxidative stress measurement.

• EZ Cap™ Cy5 EGFP mRNA (5-moUTP): Precision mRNA Delivery Wor

  2026-07-31

  EZ Cap™ Cy5 EGFP mRNA (5-moUTP) empowers real-time, dual-fluorescence tracking of both mRNA delivery and protein translation, streamlining advanced gene regulation studies. Its immune-evasive and stability-enhancing design enables high-fidelity assays in challenging cell types, including macrophages.

• Strategic Targeting of IDH1-Mutant AML: AG-120 and Metabolic

  2026-07-31

  Explore how AG-120 (Ivosidenib) redefines translational research in IDH1-mutant AML by integrating mechanistic insights from CD44-driven metabolic rewiring. This article connects biochemical rationale, experimental protocols, and evolving clinical strategies, offering actionable guidance for overcoming resistance and optimizing differentiation therapies.

• Selective ClpP Activation Induces Cell Cycle Arrest in LUSC

  2026-07-30

  A recent study reveals that ZK53, a selective activator of human ClpP, triggers cell cycle arrest and inhibits lung squamous cell carcinoma (LUSC) by disrupting mitochondrial oxidative phosphorylation and activating ATM-mediated DNA damage response. These findings offer a new mechanistic perspective on mitochondrial proteostasis as a therapeutic target in LUSC and suggest experimental strategies for dissecting nuclear-mitochondrial signaling in cancer research.

• CTCF Maintains Centromere Integrity and Mitotic Fidelity

  2026-07-30

  This study reveals that CTCF is indispensable for centromere structure and accurate chromosome segregation during mitosis. Using rapid CTCF degradation, the authors distinguish its mechanistic role from CENP-E, with implications for mitosis research and cancer biology.

• Eldecalcitol Attenuates Endothelial Ferroptosis in Diabetic

  2026-07-29

  This study uncovers how eldecalcitol, a vitamin D analog, mitigates type 2 diabetic osteoporosis by suppressing endothelial ferroptosis via the SOCE/O-GlcNAcylation axis. The findings clarify a mechanistic link between glucose-lipid metabolic stress, vascular dysfunction, and bone loss, providing a foundation for therapeutic strategies targeting endothelial health in skeletal disease.

• Cyanin Chloride Modulates Inflammation and Barrier in Psoria

  2026-07-29

  This study demonstrates that cyanin chloride, a glycosylated cyanidin derivative, exerts dual anti-inflammatory and skin barrier-restorative effects in a cytokine-induced human keratinocyte model of psoriasis. The findings clarify mechanisms involving STAT3 inhibition and filaggrin upregulation, offering actionable insights for oxidative stress and dermatological research.

• Selective CUX2 Neuron Loss in Neuroinflammation Driven by DN

  2026-07-28

  This study uncovers that upper cortical layer CUX2+ neurons are selectively vulnerable to DNA damage in neuroinflammatory conditions, such as multiple sclerosis. The work highlights the critical role of DNA damage response and repair pathways in neuronal resilience and identifies interferon-γ as a key factor driving selective neuron loss.

• Nullscript: Redefining HDAC Inhibition for Translational Imp

  2026-07-28

  Explore how Nullscript, an advanced histone deacetylase inhibitor from APExBIO, is transforming translational research by offering precise epigenetic modulation without confounding transcriptional activation. This article provides mechanistic insights, experimental strategies, and strategic guidance tailored for researchers targeting cardiac, neurodegenerative, and cancer models.

• Proteinase K Applications: Genomic DNA Isolation & Troublesh

  2026-07-27

  Unlock robust genomic DNA isolation and protein hydrolysis workflows with APExBIO's Proteinase K, a broad-spectrum serine protease engineered for contaminant removal and DNA integrity. Learn how protocol optimization and experimental troubleshooting drive reproducible results across molecular biology assays.

14723 records 1/982 page Next 12345 下5页 Last page